# Myomo, Inc.: filings

MYO · NYSE · CIK 1369290 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/myo.md) · [Financials](/companies/myo/financials.md) · [Filings](/companies/myo/filings.md) · [Insiders](/companies/myo/insiders.md)

## Reports and events: 179 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 251, 8-K 111, 144 57, 10-Q 28, SC 13G/A 25, 3 20, 4/A 18, CORRESP 16, SC 13G 16, 424B5 12, S-1/A 12, DEF 14A 11, S-8 11, DEFA14A 10, UPLOAD 10, 10-K 9, SCHEDULE 13G/A 8, EFFECT 6, D 5, ARS 4, PRE 14A 4, 1-A/A 3, 424B4 3, FWP 3, S-1 3, S-1MEF 3, S-3 3, SD 3, 1-A POS 2, 8-K/A 2, CT ORDER 2, POS EX 2, QUALIF 2, 10-K/A 1, 1-A 1, 253G2 1, 253G4 1, 5 1, 8-A12B 1, CERTNAS 1, D/A 1, DOS 1, DRS 1, S-3/A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 20:15 ET | [10-Q](/filings/0001193125-26-335149.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335149 |
| 2026-08-05 | 20:10 ET | [8-K](/filings/0001193125-26-335109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335109 |
| 2026-06-29 | 13:06 ET | [8-K/A](/filings/0001193125-26-286969.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-286969 |
| 2026-06-26 | 20:05 ET | [8-K](/filings/0001193125-26-285450.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-285450 |
| 2026-05-18 | 22:05 ET | [SCHEDULE 13D/A](/filings/0001161697-26-000118.md) | Ownership report, active investor, amended | 0001161697-26-000118 |
| 2026-05-14 | 20:05 ET | [DEF 14A](/filings/0001193125-26-223981.md) | Proxy statement, period 2026-06-25 | 0001193125-26-223981 |
| 2026-05-13 | 20:10 ET | [8-K](/filings/0001193125-26-221624.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-221624 |
| 2026-05-07 | 20:17 ET | [10-Q](/filings/0001193125-26-211988.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211988 |
| 2026-05-07 | 20:12 ET | [8-K](/filings/0001193125-26-211928.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211928 |
| 2026-04-29 | 20:05 ET | [10-K/A](/filings/0001193125-26-191496.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-191496 |
| 2026-04-16 | 20:18 ET | [8-K](/filings/0001193125-26-159060.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-159060 |
| 2026-03-09 | 20:16 ET | [10-K](/filings/0001193125-26-098531.md) | Annual report, period 2025-12-31 | 0001193125-26-098531 |
| 2026-03-09 | 20:10 ET | [8-K](/filings/0001193125-26-098504.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-098504 |
| 2025-12-29 | 23:30 ET | [SCHEDULE 13D](/filings/0001161697-25-000476.md) | Ownership report, active investor | 0001161697-25-000476 |
| 2025-12-16 | 21:18 ET | [8-K](/filings/0001193125-25-320896.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-320896 |
| 2025-11-10 | 21:15 ET | [10-Q](/filings/0001193125-25-274278.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274278 |
| 2025-11-10 | 21:10 ET | [8-K](/filings/0001193125-25-274238.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-274238 |
| 2025-08-11 | 20:15 ET | [8-K](/filings/0000950170-25-106562.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106562 |
| 2025-08-11 | 20:15 ET | [10-Q](/filings/0000950170-25-106564.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106564 |
| 2025-06-18 | 12:40 ET | [8-K](/filings/0000950170-25-087709.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-087709 |
| 2025-06-13 | 20:45 ET | [8-K](/filings/0000950170-25-086306.md) | 5.07 Shareholder vote results | 0000950170-25-086306 |
| 2025-05-07 | 20:15 ET | [10-Q](/filings/0000950170-25-065682.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065682 |
| 2025-05-07 | 20:10 ET | [8-K](/filings/0000950170-25-065657.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065657 |
| 2025-04-25 | 12:30 ET | [DEF 14A](/filings/0000950170-25-058354.md) | Proxy statement, period 2025-06-11 | 0000950170-25-058354 |
| 2025-04-10 | 12:40 ET | [8-K](/filings/0000950170-25-052686.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-052686 |
| 2025-03-10 | 20:28 ET | [10-K](/filings/0000950170-25-036349.md) | Annual report, period 2024-12-31 | 0000950170-25-036349 |
| 2025-03-10 | 20:10 ET | [8-K](/filings/0000950170-25-036280.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036280 |
| 2025-02-20 | 22:41 ET | [8-K](/filings/0000950170-25-023403.md) | 1.01 Entry into a material agreement; 2.04 Item not in the standard list; 9.01 Financial statements and exhibits | 0000950170-25-023403 |
| 2024-12-05 | 21:30 ET | [8-K](/filings/0001193125-24-271571.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271571 |
| 2024-11-06 | 21:15 ET | [10-Q](/filings/0000950170-24-122331.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122331 |
| 2024-11-06 | 21:10 ET | [8-K](/filings/0000950170-24-122298.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122298 |
| 2024-08-13 | 20:30 ET | [8-K](/filings/0000950170-24-096326.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-096326 |
| 2024-08-06 | 20:15 ET | [10-Q](/filings/0000950170-24-091839.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091839 |
| 2024-08-06 | 20:10 ET | [8-K](/filings/0000950170-24-091801.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091801 |
| 2024-07-15 | 20:05 ET | [8-K](/filings/0001193125-24-179060.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-179060 |
| 2024-07-08 | 12:45 ET | [8-K](/filings/0000950170-24-081953.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-081953 |
| 2024-06-07 | 20:05 ET | [8-K](/filings/0001193125-24-157320.md) | 5.07 Shareholder vote results | 0001193125-24-157320 |
| 2024-05-08 | 20:15 ET | [8-K](/filings/0000950170-24-055687.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055687 |
| 2024-05-08 | 20:10 ET | [10-Q](/filings/0000950170-24-055660.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055660 |
| 2024-05-06 | 12:45 ET | [8-K](/filings/0000950170-24-053228.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-053228 |
| 2024-04-26 | 12:30 ET | [DEF 14A](/filings/0001193125-24-115929.md) | Proxy statement, period 2024-06-05 | 0001193125-24-115929 |
| 2024-03-28 | 20:15 ET | [8-K](/filings/0000950170-24-038054.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-038054 |
| 2024-03-08 | 02:38 ET | [10-K](/filings/0000950170-24-028326.md) | Annual report, period 2023-12-31 | 0000950170-24-028326 |
| 2024-03-07 | 21:10 ET | [8-K](/filings/0000950170-24-027949.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-027949 |
| 2024-03-01 | 13:15 ET | [8-K](/filings/0000950170-24-023543.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-023543 |
| 2024-02-22 | 21:54 ET | [8-K](/filings/0000950170-24-018877.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-018877 |
| 2024-01-17 | 21:20 ET | [8-K](/filings/0001193125-24-009264.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-009264 |
| 2023-12-19 | 21:30 ET | [8-K](/filings/0000950170-23-071510.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-071510 |
| 2023-11-07 | 22:29 ET | [10-Q](/filings/0000950170-23-060417.md) | Quarterly report, period 2023-09-30 | 0000950170-23-060417 |
| 2023-11-07 | 21:15 ET | [8-K](/filings/0000950170-23-060269.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060269 |

Page 1 of 4. [Older](/companies/myo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.